CAMBRIDGE, Mass.--Spotfire announced that Merck has licensed its new-leads discovery system for distribution worldwide across all Merck research sites. The system, which features Spotfire Pro and Spotfire Structure Visualizer, will help Merck biologists and chemists engaged in drug discovery to identify promising drug candidates by enabling them to access and analyze information about relationships between chemical structure and biological activity.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.